Found 1263 matching trials
MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC
PHASE1The first testing of TargomiRs in the human setting: dose-finding studies i...
Location
Concord Repatriation General Hospital
Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight.
NAComputed Tomography (CT) is widely used in abdominal imaging for a variety ...
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
PHASE1Monoclonal antibodies can locate tumor cells and either kill them or delive...
Location
Children's Oncology Group
The Recovery of Cardiovascular Patients With Depression
NACardiovascular disease increases the risk of depression and vice versa. Man...
T-VEC in Non-melanoma Skin Cancer
PHASE1Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) i...
Location
Department of Dermatology, University Hospital Zurich
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
PHASE1This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Location
GSK Investigational Site
A Natural History Study to Assess the Clinical Outcomes of Patients With Complement Factor I Deficiency-Mediated Disease
N/AThis study will follow participants with a disease which is associated with...
Location
Nephrology Consultants, LLC
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
NAThe purpose of this study is to improve ways of providing mental health sup...
Location
Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities)
Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
PHASE1This is a phase I study of second primary tumor prevention in early stage (...
Location
Emory University Winship Cancer Institute
Growth Hormone (GH) Deficiency & Insulin Like Growth Factor 1 (IGF-I)/ Insulin Like Growth Factor Binding Protein 3 (IGFBP-3) Ratio
N/AA 35-month cross-sectional observational study was conducted at an outpatie...
Location
Multiple Locations